Companies: 10,795·Total market cap: $144.5T
ProSomnus, Inc.

ProSomnus, Inc.

OSANASDAQHealthcare
$0.47
+$0.00(+0.00%)
Market Cap$8175227
P/E Ratio
52W High$0.5
52W Low$0.47

ProSomnus, Inc. (OSA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

osa · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for ProSomnus, Inc. (OSA) measures how much investors pay for each dollar of the company's trailing earnings. OSA's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$1.49.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.12
Based on 1 analyst
EPS (TTM)
-$1.49
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ProSomnus, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2023 · Annual
PE Ratio (TTM)
5Y Avg 16.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
ProSomnus, Inc.
ProSomnus, Inc.You
OSA
$8MN/A-$1.49
Biora Therapeutics, Inc.
Biora Therapeutics, Inc.
BIOR
$1MN/A-$78.69
Centogene N.V.
Centogene N.V.
CNTG
$9MN/A-$1.26
COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc.
CSCI
$9MN/A-$5.93
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc.
NLTX
$8MN/A$0.00
NeuroMetrix, Inc.
NeuroMetrix, Inc.
NURO
$9MN/A-$3.96
Holdco Nuvo Group D.G Ltd. Ordinary Shares
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NUVO
$6MN/A-$1.64

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-1.49
2022-12-31
FY2022
16.86x$0.33
2021-12-31
FY2021
$-1.51
2020-12-31
FY2020
$-0.38

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for ProSomnus, Inc. (OSA) measures how much investors pay for each dollar of the company's trailing earnings. OSA's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$1.49.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.47 ÷ -$1.49 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

OSA pe ratio · 6 questions

OSA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.47 and TTM EPS of -$1.49. Data sourced from Financial Modeling Prep via OSA's SEC 10-K and 10-Q filings.

OSA PE ratioWhat is OSA PE ratioCurrent PE ratio of OSAOSA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ProSomnus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08